Skip to main content

Table 3 The laboratory findings for safety after the duration of the clinical trial

From: The effectiveness of fermented turmeric powder in subjects with elevated alanine transaminase levels: a randomised controlled study

 

Turmeric group (n = 26)

Placebo group (n = 22)

P-value1)

Baseline

12 week

Baseline

12 week

WBC (×103/μl)

6.8 ± 1.7

6.7 ± 1.7

6.2 ± 1.4

6.2 ± 1.4

0.79

RBC (×1003/μl)

5.1 ± 0.3

5.1 ± 0.4

5.0 ± 0.3

5.0 ± 0.3

0.36

Hemoglobin (g/dL)

15.9 ± 1.1

15.9 ± 1.2

15.6 ± 1.4

15.7 ± 1.3

0.21

Hematocrit (%)

45.9 ± 2.9

46.0 ± 3.4

44.8 ± 2.9

45.4 ± 3.0

0.37

Platelet (×103/μl)

252.2 ± 49.3

250.3 ± 44.3

255.6 ± 58.5

254.5 ± 62.7

0.92

Total cholesterol (mg/dl)

193.6 ± 25.2

201.7 ± 30.0

194.2 ± 34.7

198.6 ± 31.7

0.62

Triglyceride (mg/dL)

213.3 ± 114.4

220.9 ± 132.8

172.8 ± 78.0

209.4 ± 167.6

0.44

HDL-cholesterol (mg/dL)

44.1 ± 11.8

43.69 ± 11.2

45.8 ± 10.2

48.5 ± 12.1

0.16

LDL-cholesterol (mg/dL)

122.5 ± 29.4

117.3 ± 27.6

125.9 ± 38.9

113.6 ± 27.5

0.33

Glucose (mg/dL)

91.9 ± 9.7

93.0 ± 12.6

90.1 ± 8.7

89.6 ± 8.7

0.52

Total Protein (g/dL)

7.4 ± 0.3

7.48 ± 0.4

7.3 ± 0.4

7.4 ± 0.4

0.73

Albumin (g/dL)

4.6 ± 0.2

4.63 ± 0.2

4.57 ± 0.2

4.6 ± 0.3

0.79

BUN (mg/dL)

14.5 ± 4.7

13.5 ± 3.6

13.3 ± 2.6

12.9 ± 2.8

0.58

Creatinine (mg/dL)

0.85 ± 0.13

0.81 ± 0.14

0.81 ± 0.14

0.83 ± 0.14

0.12

  1. Values are presented as mean ± SD.
  2. 1) Linear mixed model for repeated measures data.